Mounjaro 5mg FAQs
What is Mounjaro 5mg used for?
Mounjaro 5mg is used to support weight loss and help manage blood sugar levels in adults with obesity or type 2 diabetes. It works best when combined with a healthy, reduced-calorie diet and regular exercise.
How does Mounjaro 5mg work?
Mounjaro 5mg contains tirzepatide, which activates GLP-1 and GIP receptors. These naturally released hormones help control blood sugar by increasing insulin release and signal the brain to promote fullness, reducing hunger and cravings, ultimately aiding weight loss.
How long does it take for Mounjaro 5mg to work?
Initial weight loss may be seen as early as 4 weeks after starting on a lower dose (such as Mounjaro 2.5mg), with an average loss of around 5 lbs (2 kg). Continued weight loss over 40 weeks can average about 25 lbs (11.3 kg) at higher doses.
Is Mounjaro 5mg effective for weight loss?
Yes, Mounjaro 5mg has proven effective in several clinical studies. In the SURPASS-2 trial, patients on higher doses experienced significant weight loss, averaging an 11% reduction or roughly 25 lbs over 40 weeks.
How do I take Mounjaro 5mg?
Mounjaro 5mg is administered as a subcutaneous injection once a week using a prefilled KwikPen. Your healthcare provider will demonstrate the correct injection technique.
Can I drink alcohol while using Mounjaro 5mg?
There are no direct interactions between Mounjaro 5mg and alcohol. However, alcohol may affect blood sugar levels and add extra calories. Consult your healthcare provider before consuming alcohol during treatment.
Do I need a prescription for Mounjaro 5mg?
Yes, a prescription is required. You must complete a health consultation with a healthcare provider to determine if Mounjaro is right for you.
Is Mounjaro 5mg safe?
Mounjaro 5mg is approved by the FDA in the US and the MHRA in the UK, with extensive research supporting its safety and effectiveness. Common side effects include nausea and diarrhea.
Can I use Mounjaro 5mg if I am pregnant or breastfeeding?
Mounjaro 5mg is not recommended during pregnancy or breastfeeding, as its effects on the unborn child and breast milk are unknown. Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Where can I buy Mounjaro 5mg in the UK?
You can obtain Mounjaro 5mg from a registered pharmacy with a prescription. Alternatively, you can purchase it online from courierpharmacy.co.uk after completing a health consultation. Approved treatments are delivered securely and discreetly.
Is Mounjaro 5mg addictive?
No, Mounjaro 5mg is not addictive. Tirzepatide helps regulate appetite and blood sugar without causing dependence.
Is Mounjaro 5mg available in generic form?
No, there is currently no generic version of Mounjaro 5mg available.
Does Mounjaro 5mg affect oral contraceptives?
If you are overweight or obese and using oral contraceptives, consider using a barrier method (such as a condom) or switching to a non-oral contraceptive for 4 weeks after starting Mounjaro and after each dose increase.
How long does Mounjaro 5mg take to work?
Studies indicate that initial weight loss can be observed as early as 4 weeks, with an average reduction of around 5 lbs (2 kg). Weight loss continues throughout 40 weeks, with an optimal dose leading to an average loss of about 25 lbs (11.3 kg).
How effective is the Mounjaro 5mg injection?
Mounjaro 5mg is highly effective in supporting weight loss. In the SURPASS-2 trial, patients on higher doses achieved significant weight reduction, averaging 11% of their body weight (approximately 25 lbs) over 40 weeks.
Which is better: Mounjaro or Ozempic?
The SURPASS-2 study compared Mounjaro at doses of 5mg, 10mg, and 15mg with once-weekly Ozempic 1mg injections. Mounjaro at 10mg and 15mg showed significantly better weight loss results than Ozempic 1mg.
After completing our online consultation form, you can securely purchase Mounjaro 5mg injection from courierpharmacy.co.uk.
References:
- Bokvist, K.B., Finan, B., Friedrichsen, S., & Heise, T. (2016). Glucagon-like peptide-1 receptor (GLP-1R) agonists combined with glucose-dependent insulinotropic peptide (GIP) receptor agonists for the treatment of metabolic disorders. United States Patent US9474780B2. Link
- ClinicalTrials.gov. (2021). SURMOUNT-1: Tirzepatide for Weight Loss in Non-Diabetic Obese Individuals. Link
- Coskun, T., et al. (2018). Tirzepatide, a dual GLP-1 and GIP receptor agonist, induces significant weight loss in patients with obesity. Diabetes Care, 41(10), 2100–2108.
- Electronic Medicines Compendium. (n.d.). Mounjaro 2.5 mg, 5 mg, 10 mg, 15 mg solution for injection in pre-filled pen [Summary of Product Characteristics]. Link
- Jastreboff, A.M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216.
- MHRA. (2023). MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss. Link
- Sinha, R., Papamargaritis, D., Sargeant, J.A., & Davies, M.J. (2023). Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management. Journal of Obesity and Metabolic Syndrome, 32(1), 25-45. DOI: 10.7570/jomes22067.
Secure your Mounjaro 5mg injection today at courierpharmacy.co.uk.